Source document or public record

FDA 510(k) K231476 — TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring System

FDA 510(k) index record K231476. Device: TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring System. Applicant as listed: Sinocare, Inc.. Decision date: 2023-12-01.

OtherU.S. Food and Drug Administration (FDA)2023-12-01

Source

"device_name": "TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring System"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K231476.

Device name: TRUENESS™ AIR Blood Glucose Monitoring System; TRUENESS™ Blood Glucose Monitoring System. Applicant as listed: Sinocare, Inc..

Decision date: 2023-12-01. Decision wording: Substantially Equivalent.

Product code: NBW. Regulation: 21 CFR 862.1345. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.